The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Open accessAbstract
Background & aims Norfloxacin is highly effective in preventing spontaneous bacterial peritonitis recurrence in cirrhosis, but its role in the primary prevention of this complication is uncertain.Methods Patients with cirrhosis and low protein ascitic levels (<15 g/L) with advanced liver failure (Child-Pugh score > or = 9 points with serum bilirubin level > or = 3 mg/dL) or impaired renal function (serum creatinine level > or = 1.2 mg/dL, blood urea nitrogen level > or = 25 mg/dL, or serum sodium level < or = 130 mEq/L) were included in a randomized controlled trial aimed at comparing norfloxacin (35 patients) vs placebo (33 patients) in the primary prophylaxis of spontaneous bacterial peritonitis. The main end points of the trial were 3-month and 1-year probability of survival. Secondary end points were 1-year probability of development of spontaneous bacterial peritonitis and hepatorenal syndrome.Results Norfloxacin administration reduced the 1-year probability of developing spontaneous bacterial peritonitis (7% vs 61%, P < .001) and hepatorenal syndrome (28% vs 41%, P = .02), and improved the 3-month (94% vs 62%, P = .003) and the 1-year (60% vs 48%, P = .05) probability of survival compared with placebo.Conclusions Primary prophylaxis with norfloxacin has a great impact in the clinical course of patients with advanced cirrhosis. It reduces the incidence of spontaneous bacterial peritonitis, delays the development of hepatorenal syndrome, and improves survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to norfloxacin, rifaximin has been noted to increased survival in patients with advanced liver cirrhosis in several small-scale trials92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Moreover, several small-scale clinical studies have suggested that antibiotics such as norfloxacin and rifaximin increase survival in patients with liver cirrhosis92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
Arroyo, V., Ginès, P., Gerbes, A. L., Dudley, F. J., Geñtilini, P., Laffi, G., Reynolds, T. B., Ring‐Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,694
Self-citationSort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruíz-del-Árbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410603 · Cited by 1,636
Self-citationDiagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
Rimola, A., García–Tsao, G., Navasa, M., Piddock, L. J. V., Planas, R., Bernard‐Chabert, B., & Inadomi, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80201-9 · Cited by 1,058
Self-citationFernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Self-citationIncidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginés, À., Escorsell, À., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 874
Self-citationGinés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Self-citationFollo, A., Llovet, J. M., Navasa, M., Planas, R., Forns, X., Francitorra, A., Rimola, A., Gassull, M. A., Arroyo, V., & Rodés, J. (1994) · Hepatology · doi:10.1002/hep.1840200619 · Cited by 597
Self-citationCirculatory function and hepatorenal syndrome in cirrhosis†
Ruíz-del-Árbol, L., Monescillo, A., Arocena, C., Valer, P., Ginès, P., Moreira, V., Milicua, J. M., Jiménez, W., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20766 · Cited by 584
Self-citationRuíz-del-Árbol, L., Urmán, J., Fernández, J., González, M., Navasa, M., Monescillo, A., Albillos, A., Jiménez, W., & Arroyo, V. (2003) · Hepatology · doi:10.1053/jhep.2003.50447 · Cited by 496
Self-citationLlach, J., Ginès, P., Arroyo, V., Rimola, A., Titó, L., Badalamenti, S., Jiménez, W., Gaya, J., Rivera, F., & Rodés, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90441-6 · Cited by 457
Self-citation
Flagged first, then by citations
2 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 709
Magnitude of Clostridium Difficile Infection in Hospitalized Egyptian Patients with Liver Cirrhosis
Tharwa, E., Abdel‐Samiee, M., Gabal, A. A., & Aziz, A. A. E. (2017) · Applied Microbiology open access · doi:10.4172/2471-9315.1000127
Altaf, J. (2017) · International Clinical Pathology Journal · doi:10.15406/icpjl.2017.04.00105
Current Trends in the Management of Spontaneous Bacterial Peritonitis
Ho, C. K., & Asrani, S. K. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0355-9
péritonite bactérienne spontanée
Restellini, S., Nendaz, M., & Morard, I. (2012)
Ascites and Spontaneous Bacterial Peritonitis
Patidar, K. R., & Sanyal, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47874-8.00013-4
Renal Complications of Liver Disease and the Hepatorenal Syndrome
Cheng, X. S., & Kim, W. R. (2017) · doi:10.1002/9781119251316.ch13
Cirrhosis and Portal Hypertension: Staging and Prognosis
García–Tsao, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-72628-1_1
A COMPREHENSIVE INFORMATIVE NOTE ON ASCITES
Singh, N., Patyar, S., & Talniya, N. C. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i4.22948
Modulation of the gut-liver axis in cirrhosis with activated carbon
Macnaughtan, J. (2017) · UCL Discovery (University College London)
Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome
Piano, S. S., Tonon, M., & Angeli, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00084-4
Pathophysiology and Management of the Hepatorenal Syndrome
Piano, S. S., Tonon, M., & Angeli, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00128-x
Renal Function in Chronic Liver Disease
Annie, K. B. (2010)
Belcher, J. M., & Parikh, C. R. (2018) · Springer eBooks · doi:10.1007/978-1-4939-8628-6_7
Rajeswari, J. J. (2015) · Indian Journal of Microbiology Research
Dutta, S., Chawla, S., Srivastava, S., Loomba, P. S., & Roy, V. (2018) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20184329
Hepatobiliary Quiz Answers – 18 (2016)
Rathi, S., & Dhiman, R. K. (2016) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2016.06.174
Brauns, E., & Gustot, T. (2019) · Wiley eBooks · doi:10.1002/9781119211419.ch26
Ascites, Hyponatremia, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome
Piano, S. S., Tonon, M., & Angeli, P. (2019) · Wiley eBooks · doi:10.1002/9781119211419.ch43
Antibiotika und der Gastrointestinaltrakt – Update 2019
Lübbert, C. (2019) · Gastroenterologie up2date · doi:10.1055/a-0641-1861
Prognosis, Prevention and Research Prospects of Progression to Severe Hepatitis B (Liver Failure)
Wang, Y., Yang, D., Wang, M., Selzner, N., Farrokhi, K., Chruscinski, A. J., & Levy, G. A. (2019) · Springer eBooks · doi:10.1007/978-94-024-1603-9_6
Renal Dysfunction in Patients with Cirrhosis
Francoz, C., Durand, F., Haddad, Z., Hamiduzzaman, K., Khemichian, S., Maw, T. T., Genyk, Y., & Nadim, M. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-24490-3_5
Cinader, B. (1975) · PubMed
The pattern of microbial flora in Spontaneous bacterial peritonitis in Cirrhotic patients
Asif, S. J., Gondal, M., Perveen, S., Mushtaq, S., Awan, S., & Hussain, T. (2020) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc/vol24.iss1.13
Cadranel, J., & Nousbaum, J. (2020) · OBM Hepatology and Gastroenterology · doi:10.21926/obm.hg.2002045
Intestinal Microbiome and the Liver
Gillevet, P. M., & Puri, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00003-3
Cheng, I. K. P., & Li, F. F. K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05876-6.00072-1
Guevara, M., & Rodés, J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1725-9.10012-7
Perioperative critical care in hepatopancreatobiliary patients
Voigt, L. P., Pastores, S. M., & Halpern, N. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34062-5.00025-x
Cirrhosis; Management of Spontaneous Bacterial Peritonitis and Other Infections
Hernández-Tejero, M., Carpio, A., & Fernández, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65722-7
Self-citationSmith, R. E., Friedman, A. D., Murchison, J. A., Tanner, S. B., Smith, P., & Dollar, B. T. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00435-5
Acute Kidney Injury in Hepatico-Pancreatic-Biliary Surgery and Liver Transplantation
Kim, W. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-51331-3_14
TRANSLOCATION OF INTESTINAL MICROFLORA IN CIRRHOSIS
Haurylenka, D. I., & Силивончик, Н. Н. (2020) · Hepatology and Gastroenterology · doi:10.25298/2616-5546-2020-4-2-143-150
Spontaneous bacterial peritonitis in a 45-year-old man with ethanolic liver cirrhosis
Universitatea de Medicină și Farmacie „Carol Davila“, B., Mirică, R. E., Institutul Național de Expertiză Medicală și Recuperare a Capacității de Muncă, B., Rouhani, F., Neamţu, D., & Institutul Național de Expertiză Medicală și Recuperare a Capacității de Muncă, B. (2020) · Romanian Medical Journal · doi:10.37897/rmj.2020.2.17
Surace, M., Andria, I., & VALENTINI, G. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02816-6
ShiYu-Chen, K.-Q., Ying, F., & LinMei, X.-F. (2012)
Clinical Practice of Hepatorenal Syndrome: A Brief Review on Diagnosis and Management
Rendy, Febyan, F., & Wetarini, K. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.2.743
Infektionen und Lebertransplantation
Queck, A., Ferstl, P. G., Bruns, T., & Trebicka, J. (2021) · Die Gastroenterologie · doi:10.1007/s11377-021-00521-7
ortal Hypertension and Its Complications
Sanyal, A. J., Bosch, J., Blei, A. T., & Arroyo, V. (2008)
Self-citationRazafindrazoto, C. I., Rakotozafindrabe, A. L. R., & Rabenjanahary, T. H. (2021) · African Journal of Nephrology · doi:10.21804/24-1-4598
Management of Renal Disease in the Liver Transplant Candidate
Cárdenas, A., & Ginès, P. (2012) · doi:10.1002/9781444398441.ch4
Self-citationFábrega, E., Huelin, P., Fortea, J. I., & Crespo, J. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.04.004
Gupta, M. M., & Deng, X. (2021) · Springer eBooks · doi:10.1007/978-3-030-83082-3_9
O’Riordan, A. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5547-8_8
(2012) · Elsevier eBooks · doi:10.1016/b978-0-323-08373-7.00025-x
Acute Kidney Injury in Cirrhosis
Francoz, C., Durand, F., Genyk, Y., & Nadim, M. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00045-5
Henriksen, J. H., & Møller, S. (2013) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00085ed1v01y201305isp039
Hinz, M., Witzke, O., Gerken, G., & Canbay, A. E. (2013) · Der Nephrologe · doi:10.1007/s11560-012-0737-5
Judd, E. K., Mehta, S. G., & Tolwani, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4454-1_21
Zink, W. (2014) · Springer eBooks · doi:10.1007/978-3-642-44933-8_17
Lemoinne, S., Cadoret, A., Bosselut, N., Housset, C., Wendum, D., & Thabut, D. (2012) · EMC - Hépatologie · doi:10.1016/s1155-1976(12)59788-3
Yeboah, M. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_32
Mohindra, S., & Kumar, K. (2013) · Clinical Queries Nephrology · doi:10.1016/j.cqn.2013.11.002
Ginès, P., & Ariza, X. (2019) · Encyclopedia of Gastroenterology · doi:10.1016/b978-0-12-801238-3.65716-1
Self-citationPeritonitis, Spontaneous Bacterial
Ginés, P., & Guevara, M. (2009) · Springer eBooks · doi:10.1007/978-3-540-29676-8_1660
Self-citationFernández, J., & Navasa, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.005
Self-citationInfections in Cirrhosis in Critical Care
Preheim, L. C. (2009) · Infectious disease and therapy · doi:10.3109/9781420092417.019
Huschak, G., Kaisers, U. X., & Laudi, S. (2015) · Springer eBooks · doi:10.1007/978-3-662-46515-8_1
(2012) · Elsevier eBooks · doi:10.1016/b978-0-323-08373-7.00017-0
Dhillon, A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00099-9
(2012) · Elsevier eBooks · doi:10.1016/b978-0-323-08373-7.00012-1
Moreau, R., Francoz, C., Lebrec, D., & Durand, F. (2010) · Elsevier eBooks · doi:10.1016/b978-2-8101-0186-3.50010-2
Pillebout, É. (2011) · Encyclopédie médico-chirurgicale. Néphrologie · doi:10.1016/s1762-0945(11)58254-3
Renal Dysfunction in Patients with Liver Cirrhosis
Sobh, M., Abdalbary, M., Abdelsalam, M., & El-Husseini, A. A. (2022) · Digestive Disease Interventions · doi:10.1055/s-0042-1746192
Arroyo, V., & Guevara, M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_22
Self-citationPrognostic Factors in Patients with CirrhosisPreprint
Rasheed, M. H., Aldouh, M., Aldeen, M. A., & Ali, A. F. (2022) · Research Square · doi:10.21203/rs.3.rs-2156203/v1
Juanola, A., Cárdenas, A., & Ginès, P. (2022) · doi:10.1002/9781119105954.ch9
Self-citationSYNDROME OF SYSTEMIC INFLAMMATORY RESPONSE AND SEPSIS IN PATIENTS WITH LIVER CIRRHOSIS
Малаева, Е. Г. (2011) · Health and Ecology Issues · doi:10.51523/2708-6011.2011-8-2-2
Prevention of Further Decompensation in Patients With Ascites
Piano, S. S., Reiberger, T., Larrue, H., & Bureau, C. (2022) · Springer eBooks · doi:10.1007/978-3-031-08552-9_49
Study of Spontaneous Bacterial Peritonitis Antimicrobial Sensitivity Pattern in Cirrhotic Patients
Mostafa, M., Gad, M., Bayoumi, H., Ebrahim, A., & Elgazar, A. H. A. (2022) · Benha Journal of Applied Sciences · doi:10.21608/bjas.2022.274375
Masnou, H., Aguilar, A., Iborra, I., Sala, M., Torner, M., Clos, A., Ardèvol, A., Giménez, M., Fortuny, M., Sarrias, M., et al. (2023) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2022.09.003
Afectación renal en la enfermedad hepática crónica avanzada. Síndrome hepatorrenal
Ibáñez, L., Baines, A., & Bañares, R. (2023) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2023.06.010
Kamran, M. A., Saeed, M. I., Shah, H. A., Sattar, S., & Butt, A. (2023) · Global Gastroenterology · doi:10.21608/gg.2023.207153.1017
Kidney–Liver Crosstalk in Acute Kidney Injury
Gadano, A. C., Colombo, M., & Musso-Enz, V. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-36789-2_12
Deorukhkar, D. D., Sonawale, A., Goyal, A., & Sonawale, K. (2023) · Cureus · doi:10.7759/cureus.47927
Thapa, P. (2022) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2022.19.556004
Prophylaxis and Treatment of Bacterial Infections in Cirrhosis
Gilbert, L., & Fricker, Z. P. (2024) · Current Hepatology Reports · doi:10.1007/s11901-024-00633-y
de Mattos, Â. Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-87031-3.00028-7
Five-year Trends of Fungal Infections in Cirrhotic Patients: Nationwide Study From 2016-2020Preprint
Choday, S., Alomar, T., & Wong, R. J. (2024) · Research Square · doi:10.21203/rs.3.rs-4125927/v1
Padhi, P. K., Patra, S., & Bagudai, A. K. (2024) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2024.v84i03.003
Care of the Patient with End-Stage Liver Disease
Krok, K. L. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4160-2455-2.00027-x
Temporal Trends of Fungal Infections in Cirrhotic Patients: A Retrospective Cohort Study 2016–2020
Silpa, C., Alomar, T., & Wong, R. J. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.102469
Croatian guidelines for the diagnosis and treatment of portal hypertension
Grgurević, I. (2024) · Acta Clinica Croatica · doi:10.20471/acc.2024.63.01.27
Bernardi, M., & Zaccherini, G. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_22
DiazGranados, D., O’Leary, J. G., Yamuzala, M., Rogal, S. S., & Bajaj, J. S. (2025) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000858
Current Status and Future Directions in the Pharmacologic Management of Cirrhosis
Bunchorntavakul, C., & Reddy, K. R. (2025) · Clinics in Liver Disease · doi:10.1016/j.cld.2025.06.003
Acute-on-chronic liver failure
Habib, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21938-2.00016-3
Lin, T., Wu, X., Lan, Y., Huang, Y., Deng, Z., Zhang, Y., Lynch, M., Long, H., & Pan, J. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00233-25
Thévenot, T., Desmarets, M., & Tio, G. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.10.004
Hepatorenal syndrome: current insights and future perspectives
Enyetornye, B., Acheampong, O. D., Dogodzi, F. K., & Osei, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33090-2.00003-5
Medikamentöse Therapie der Komplikationen der Leberzirrhose
Grünhage, F., Heller, J., Appenrodt, B., Schmitz, V., & Sauerbruch, T. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1072-5
Ennaifer, R., Elleuch, N., Cheikh, M., Romdhane, H., Nejma, H. B., & Hadj, N. B. (2015) · Journal Africain d Hépato-Gastroentérologie · doi:10.1007/s12157-015-0606-8
Hillert, A., Schultalbers, M., Tergast, T. L., Vonberg, R.-P., Rademacher, J., Wedemeyer, H., Cornberg, M., Ziesing, S., Maasoumy, B., & Höner zu Siederdissen, C. (2021) · Figshare · doi:10.6084/m9.figshare.15026643
Park, J., Kim, B. W., Choi, H. J., Hong, S. H., Park, C. S., Choi, J. H., & Chae, M. S. (2020) · Figshare · doi:10.6084/m9.figshare.11972400
Park, J., Kim, B. W., Choi, H. J., Hong, S. H., Park, C. S., Choi, J. H., & Chae, M. S. (2020) · Figshare · doi:10.6084/m9.figshare.11972394
Hillert, A., Schultalbers, M., Tergast, T. L., Vonberg, R.-P., Rademacher, J., Wedemeyer, H., Cornberg, M., Ziesing, S., Maasoumy, B., & Höner zu Siederdissen, C. (2021) · Figshare · doi:10.6084/m9.figshare.15026649
Song, S., Yang, Y., Geng, C., Tang, Z., Wang, C., & Li, X. (2023) · Figshare · doi:10.6084/m9.figshare.24046088
Park, J., Kim, B. W., Choi, H. J., Hong, S. H., Park, C. S., Choi, J. H., & Chae, M. S. (2020) · Figshare · doi:10.6084/m9.figshare.11972385
Park, J., Kim, B. W., Choi, H. J., Hong, S. H., Park, C. S., Choi, J. H., & Chae, M. S. (2020) · Figshare · doi:10.6084/m9.figshare.11972382
Hillert, A., Schultalbers, M., Tergast, T. L., Vonberg, R.-P., Rademacher, J., Wedemeyer, H., Cornberg, M., Ziesing, S., Maasoumy, B., & Höner zu Siederdissen, C. (2021) · Figshare · doi:10.6084/m9.figshare.15026652
Hillert, A., Schultalbers, M., Tergast, T. L., Vonberg, R.-P., Rademacher, J., Wedemeyer, H., Cornberg, M., Ziesing, S., Maasoumy, B., & Höner zu Siederdissen, C. (2021) · Figshare · doi:10.6084/m9.figshare.15026640
Metadata
- Authors
- Fernández, J., Navasa, M., Planas, R., Montoliu, S., Monfort, D., Soriano, G., Vila, C., Pardo, A., Quintero, E., Vargas, V., Such, J., Ginès, P., & Arroyo, V.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital de Sant Pau (ES)
- Hospital Del Mar (ES)
- Hospital Universitario de Canarias (ES)
- Corresponding author
- Navasa, Miquel
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 133
- Issue
- 3
- Pages
- 818-824
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2012746560
- Cited by
- 709
- References
- 36
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 23 · 2023: 37 · 2022: 28 · 2021: 43 · 2020: 39 · 2019: 42 · 2018: 42 · 2017: 37 · 2016: 34 · 2015: 55 · 2014: 48 · 2013: 31 · 2012: 46
- FWCI
- 30.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Keywords
- spontaneous bacterial peritonitis, primary prophylaxis, norfloxacin, hepatorenal syndrome, liver cirrhosis, survival, renal dysfunction, antibiotic prophylaxis
- MeSH terms
- Aged, Anti-Infective Agents, Double-Blind Method, Female, Hepatorenal Syndrome, Humans, Liver Cirrhosis, Male, Middle Aged, Norfloxacin, Peritonitis, Risk Factors, Survival Analysis, Antibiotic Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
